申请人:NAT INST OF BIOLOG SCIENCES BEIJING
公开号:WO2016101887A1
公开(公告)日:2016-06-30
The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
该发明提供了抑制细胞坏死和/或人类受体相互作用蛋白1激酶(RIP1)的酰胺,包括相应的磺酰胺,以及其药用盐、氢化物和立体异构体。这些化合物用于制备药物组合物,并用于制备方法,包括用有效量的化合物或组合物治疗需要的人,并检测人的健康或状况的改善。